Not Tagged
novartis
['breast', 'novartis']
this #asco22, will be presenting new matching-adjusted indirect comparison quality of life results on our cdk4/6 inhibitor in #metastaticbreastcancer. learn more about this method used to compare two treatment options 
Committed to providing medical & scientific disease education information to healthcare professionals. See our community guidelines: https://t.co/pj8hG1sQAu